Template of a page 

Outcomes for patients receiving optimal exposure to imatinib are similar to other TKI

Sub-optimal responses and treatment failures with imatinib may be address4ed by exposure evaluation and dosing optimization.12,13

  • Help avoid sub-optimal therapeutic response

  • Help identify potential non-adherence to therapy

  • Help reduce toxicity in patients receiving too much drug, potentially improving the patient’s quality of life

 

Saladax Resources

5Fu FU FU FU

5Fu FU FU FU

Poster presented at Asco

 
stuff

stuff

stuff

 

Publications of Interest

 
 
Is BSA Outdated

Is BSA Outdated

 

Text For Button

 

Text For Button